As of July 2026, 148 paid clinical trials are recruiting in Westwood, Kansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Westwood offers studies at sites including University of Kansas Hospital-Westwood Cancer Center for conditions such as Acute Myeloid Leukemia, Breast Cancer, Malignant Solid Neoplasm, Non-Hodgkin Lymphoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Westwood, KS at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Kansas Hospital-Westwood Cancer Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Stage IV Lung Cancer AJCC v8 | 70 |
| University of Kansas Cancer Center | Breast Cancer, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 19 |
| The University of Kansas Cancer Center | Breast Cancer, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia | 16 |
| University of Kansas | Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Autoimmune Diseases | 6 |
| The University of Kansas Cancer Center - Westwood | Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Cutaneous Squamous Cell Cancer | 6 |
| University of Kansas Medical Center | AML (Acute Myelogenous Leukemia), Acute Leukemia (Category), Acute Lymphoid Leukemia (ALL) | 5 |
| Kansas University Medical Center | Multiple Myeloma, Neoplasms | 2 |
| The University of Kansas Medical Center | Advanced Solid Tumors, FGF19 Gene Amplification, FGF19 Gene Overexpression | 2 |
| University of Kansas Cancer Center - Westwood | Advanced Melanoma, MF, Myelofibrosis | 2 |
| University of Kansas Clinical Research Center | Refractory Multiple Myeloma, Relapsed Multiple Myeloma, Stage III Fallopian Tube Cancer | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| GSK Investigational Site | Colonic Neoplasms, Neoplasms, Colon | 1 |
| KUCC - Briarcliff | Breast Cancer | 1 |
| KUCC - Olathe | Breast Cancer | 1 |
| Local Institution - 0216 | Follicular Lymphoma | 1 |
| The University of Kansas Cancer Center (KUCC) - Westwood | Advanced Melanoma | 1 |
| The University of Kansas Cancer Center Westwood | Solid and Hematological Malignancies | 1 |
| The University of Kansas Cancer Center-Westwood | Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis | 1 |
| The University of Kansas Clinical Research Center | CRC, Colorectal Cancer, Gastrointestinal Cancer | 1 |
| The University of Kansas Hospital | Triple Negative Breast Cancer | 1 |
| University of Kansas Cancer Center SC | Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program | 1 |
| University of Kansas Cancer Center Westwood | Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer | 1 |
| University of Kansas Cancer Center-Westwood | Chronic Graft-Versus-Host Disease (cGVHD) | 1 |
| University of Kansas Hospital | Melanoma | 1 |
| University of Kansas Hospital- Westwood Cancer Center | Cutaneous Melanoma, Stage II | 1 |
Recruiting trials in Westwood grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 148 recruiting clinical trials in Westwood, Kansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Westwood compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Westwood include Acute Myeloid Leukemia (8), Breast Cancer (6), Malignant Solid Neoplasm (4), Non-Hodgkin Lymphoma (4), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Westwood on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Westwood include University of Kansas Hospital-Westwood Cancer Center, University of Kansas Cancer Center, The University of Kansas Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Westwood are Cancer & tumors (125), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.